Cochlear Nucleus Hybrid Implant System

Cochlear America’s received a FDA approval for the Cochlear™ Nucleus® Hybrid Implant System. The Nucleus Hybrid System is a groundbreaking advancement that will change the way hearing loss is treated in the United States, expanding the scope of implantable hearing technology to a whole new indication.

The Nucleus Hybrid System is comprised of the Nucleus Hybrid L24 Implant and the Cochlear™ Nucleus® 6 Sound Processor with Cochlear Hybrid® Hearing. This system is designed to effectively restore access to high frequencies resulting in a speech understanding improvement 2X greater than with a hearing aid alone.

The Hybrid L24 electrode is not only thin, but shorter in length to specifically allow for a shallower insertion depth that will accommodate high frequency stimulation of spiral ganglion cells and acoustic low frequency stimulation of hair cells. This is the essence of Hybrid; electric and acoustic stimulation combined to deliver patients a full spectrum of hearing through a single device.

















Home Page Meet Our Physicians & Staff Contact Us